Keyphrases
Tumor
100%
Estrogen Receptor
100%
Malignant Pleural Mesothelioma
100%
EGF Receptor
100%
Estrogen Receptor β
100%
Gefitinib
100%
Affect Responses
100%
Receptor Inactivation
100%
Mesothelioma Cells
16%
Receptor Activation
16%
Cell Proliferation
16%
Signal Transduction Pathway
16%
Malignancy
8%
Tumor Cells
8%
Estrogen
8%
Oncogenesis
8%
Molecular Mechanism
8%
Clinical Outcomes
8%
Knockdown
8%
Invasive Phenotype
8%
Constitutive Activation
8%
Therapeutic Agents
8%
Re-expression
8%
Caveolin-1 (Cav-1)
8%
Receptor 1
8%
Differential Expression
8%
Independent Prognostic Factor
8%
Physical Interaction
8%
Anchorage-independent Growth
8%
Reduced Activation
8%
Anchorage-independent
8%
Translational Implications
8%
Medicine and Dentistry
Neoplasm
100%
Estrogen Receptor
100%
Pleura Mesothelioma
100%
Epidermal Growth Factor Receptor
100%
Gefitinib
100%
Estrogen Receptor Beta
100%
Cell Proliferation
16%
Signal Transduction Pathway
16%
Tumor Cell
8%
Prognostic Factor
8%
Cancer
8%
Carcinogenesis
8%
Protein Kinase B Inhibitor
8%
Anchorage Independent Growth
8%
Mesothelioma Cell Line
8%
Anchorage
8%
Internalization
8%
Therapeutic Agent
8%
Caveolin 1
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Estrogen Receptor
100%
Pleura Mesothelioma
100%
Epidermal Growth Factor Receptor
100%
Gefitinib
100%
Estrogen Receptor Beta
100%
Carcinogenesis
8%
Caveolin 1
8%
Protein Kinase B Inhibitor
8%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Estrogen Receptor
100%
Estrogen Receptor Beta
100%
Gefitinib
100%
Signal Transduction
16%
Cell Proliferation
16%
Carcinogenesis
8%
Internalization
8%
Anchorage Independent Growth
8%
Caveolin 1
8%